Overview of the Federal Service for Surveillance in Healthcare (Roszdravnadzor) and Medical Device Registration in Russia

Federal Service for Surveillance in Healthcare (Roszdravnadzor) - Overview

The Federal Service for Surveillance in Healthcare (Roszdravnadzor) is the federal executive body responsible for state control, surveillance, and regulation of healthcare, pharmaceuticals, and medical devices within the Russian Federation. Operating under the Ministry of Health, Roszdravnadzor ensures that only high-quality, safe, and effective medical technologies are legally manufactured, imported, distributed, and used in Russian healthcare networks.

Key Roles and Responsibilities

Roszdravnadzor manages the comprehensive authorization lifecycle of medical products through several core mandates:

• State Registration: No medical device or in vitro diagnostic (IVD) product can be legally imported, commercialized, or used in clinics within Russia without first obtaining a State Registration Certificate (Registratsionnoe Udostoverenie) issued directly by Roszdravnadzor.

• Risk Classification: Devices are categorized based on their potential risk under four distinct groups matching international standards:

• Class 1: Low risk (e.g., standard surgical instruments, bandages).

• Class 2a: Medium risk (e.g., diagnostic ultrasound equipment, contact lenses).

• Class 2b: Increased risk (e.g., ventilators, X-ray equipment).

• Class 3: High risk (e.g., cardiac pacemakers, active implantable devices).

• Testing Oversight: Oversees mandatory national testing including technical, toxicological, electromagnetic compatibility (EMC), software validation, and biological safety assessments performed exclusively in accredited Russian laboratories.

• Clinical Trial Evaluation: Reviews technical dossiers in a phased process to authorize clinical investigations on Russian territory and subsequently analyzes clinical efficacy and safety data to approve commercial access.

• Market Surveillance and Materiovigilance: Operates post-market quality control networks, tracking manufacturer incident reports (MIR), executing safety recalls, and regulating medical device advertising.

Dual Regulatory Systems: Russia National vs. EAEU Framework

Currently, medical device suppliers can choose between two operational registration pathways:

1. Russian National System: Regulated by Government Decree No. 1416 / Resolution No. 1684. Certificates issued under this pathway are valid indefinitely within the Russian Federation.
2. Eurasian Economic Union (EAEU) System: Aligned with the unified regional framework (including Armenia, Belarus, Kazakhstan, Kyrgyzstan, and Russia). Registration via a chosen "Reference State" grants broader entry into the unified EAEU common market. Transition timelines allow both systems to coexist until a full harmonized framework takes mandatory effect.